...
首页> 外文期刊>Archives of virology >Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus
【24h】

Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus

机译:Dengue-2病毒的核衣壳样颗粒增强了对Dengue-4病毒的重组蛋白的免疫应答

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we evaluate in mice a novel formulation containing nucleocapsid-like particles of dengue-2 virus (recNLP) co-immunized with a chimeric protein composed of the dengue-4 envelope domain III fused twice within the meningococcal P64k protein of Neisseria meningitidis (PD24). The animals receiving the PD24-recNLP mixture showed the highest levels of antiviral antibodies. Similar results were obtained for IFNγ secretion levels, indicating a functional Th1 cellular response. Consistently, the percentage of mice surviving after viral challenge was significantly higher for those immunized with the mixture than for those inoculated with PD24 protein alone. In addition, in vivo depletion experiments demonstrated the decisive role of CD4+ and CD8+ cells in the protection conferred by immunization with PD24-recNLP. In conclusion, this report demonstrates for the first time the adjuvant capacity of dengue-2 virus recNLP. Additionally, the evidence presented highlights the potential of these particles for enhancing the immune response against heterologous recombinant proteins.
机译:在这项研究中,我们评估小鼠的小鼠含有尼瓜衣壳样颗粒的统一-2病毒(RECNLP)的新型制剂,其与嵌合蛋白组成的嵌合蛋白质组成的嵌合蛋白融合在脑膜炎敏尼序的脑膜炎球菌P64K蛋白中融合两次(PD24)。接受PD24-RECNLP混合物的动物显示出最高水平的抗病毒抗体。为IFNγ分泌水平获得了类似的结果,表明功能性Th1细胞反应。始终如一地,对于用混合物免疫的那些,病毒攻击后存活的小鼠百分比显着高于单独用PD24蛋白接种的那些。此外,在体内耗尽实验中,证明了CD4 +和CD8 +细胞在通过免疫接种PD24-RECNLP赋予保护中的决定性作用。总之,本报告首次证明了登革热-2病毒RECNLP的佐剂能力。另外,提出的证据突出了这些颗粒的潜力,用于增强异源重组蛋白的免疫应答。

著录项

  • 来源
    《Archives of virology》 |2010年第10期|共9页
  • 作者单位

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    PAHO/WHO Collaborating Center for Viral Diseases Department of Virology Pedro Kourí Tropical;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    PAHO/WHO Collaborating Center for Viral Diseases Department of Virology Pedro Kourí Tropical;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

    Vaccine Division Center for Genetic Engineering and Biotechnology (CIGB) P.O. Box. 6162 10600;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学微生物学(病原细菌学、病原微生物学);
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号